An Australian tuberous sclerosis cohort: Are surveillance guidelines being met?

Journal of Paediatrics and Child Health

Volumn 47, Issue 10, 2011, Pages 711-716

  Chopra, Maya ^a,b,c,d   Lawson, John A ^a,b   Wilson, Meredith ^c,d   Kennedy, Sean E ^a   Taylor, Peter ^e   Buckley, Michael F ^e,g   Wargon, Orli ^a   Parasivam, Gayathri ^a   Camphausen, Christoph ^a,b   Yates, Deborah ^f   Mowat, David ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e South Eastern Area Laboratory Services   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

TSC surveillance; TSC1 mutation; TSC2 mutation; tuberous sclerosis complex

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEALTH SURVEY; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MALE; NEWBORN; PEDIATRICS; PHENOTYPE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 80054801258     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02038.x     Document Type: Article

References (26)

1. Osborne JP, Fryer A, Webb D,. Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci. 1991; 615: 125-7.
2. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305-15.
3. van Slegtenhorst M, de Hoogt R, Hermans C, et al,. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805-8. (Pubitemid 27366729)
4. Dabora SL, Jozwiak S, Franz DN, et al,. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 2001; 68: 64-80. (Pubitemid 32048362)
5. Au KS, Williams AT, Roach ES, et al,. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet. Med. 2007; 9: 88-100.
6. Sancak O, Nellist M, Goedbloed M, et al,. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur. J. Hum. Genet. 2005; 13: 731-41. (Pubitemid 40846845)
7. Jones AC, Daniells CE, Snell RG, et al,. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum. Mol. Genet. 1997; 6: 2155-61. (Pubitemid 27477959)
8. Jones AC, Shyamsundar MM, Thomas MW, et al,. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet. 1999; 64: 1305-15. (Pubitemid 30468748)
9. Proud CG,. Cell signaling. mTOR, unleashed. Science 2007; 318: 926-7.
10. Bissler JJ, McCormack FX, Young LR, et al,. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 2008; 358: 140-51.
11. Franz DN, Leonard J, Tudor C, et al,. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann. Neurol. 2006; 59: 490-8. (Pubitemid 43358069)
12. Koenig MK, Butler IJ, Northrup H,. Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex. J. Child. Neurol. 2008; 23: 1238-9.
13. Krueger DA, Care MM, Holland K, et al,. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 2010; 363: 1801-11.
14. Roach ES, DiMario FJ, Kandt RS, Northrup H,. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J. Child. Neurol. 1999; 14: 401-7. (Pubitemid 29321101)
15. O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP,. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004; 94: 853-7. (Pubitemid 39472484)
16. Hancock E, Osborne J,. Lymphangioleiomyomatosis: a review of the literature. Respir. Med. 2002; 96: 1-6. (Pubitemid 41122762)
17. Roach ES, Gomez MR, Northrup H,. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J. Child. Neurol. 1998; 13: 624-8. (Pubitemid 29035481)
18. Qin W, Kozlowski P, Taillon BE, et al,. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex. Hum. Genet. 2010; 127: 573-82.
19. Lewis JC, Thomas HV, Murphy KC, Sampson JR,. Genotype and psychological phenotype in tuberous sclerosis. J. Med. Genet. 2004; 41: 203-7. (Pubitemid 38333799)
20. Osborne JP, Merrifield J, O'Callaghan FJ,. Tuberous sclerosis-what's new? Arch. Dis. Child. 2008; 93: 728-31.
21. Franz DN, de Vries PJ, Crino PB,. Giant cell astrocytomas in tuberous sclerosis complex. Arch. Dis. Child. 2009; 94: 75-6.
22. O'Callaghan FJ, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP,. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch. Dis. Child. 2008; 93: 751-4.
23. Williams JM, Racadio JM, Johnson ND, Donnelly LF, Bissler JJ,. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am. J. Kidney Dis. 2006; 47: 95-102. (Pubitemid 41828271)
24. Ewalt DH, Diamond N, Rees C, et al,. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J. Urol. 2005; 174: 1764-6. (Pubitemid 41546930)
25. Johnson SR, Cordier JF, Lazor R, et al,. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35: 14-26.
26. Johnson SR,. Lymphangioleiomyomatosis. Eur. Respir. J. 2006; 27: 1056-65. (Pubitemid 44911122)